COVID-19 Deployed Vaccine Cohort Study (DOVE) [COVID-19]
Research type
Research Study
Full title
An observational study to determine the cross-specificity of B and T cell responses in people who have been vaccinated with deployed COVID-19 vaccines.
IRAS ID
295128
Contact name
Emma Thomson
Contact email
Duration of Study in the UK
5 years, 0 months, 0 days
Research summary
This is an observational study to determine the processes that allow immunity to develop in those who have received any current approved SARS-CoV-2 vaccine against SARS-CoV-2 virus and any virus variants. Blood samples will be collected from groups of people who have received either 1 or 2 doses of a regulatory authorised COVID-19 vaccine as part of routine care. The presence of Immune system cell type responses will be assayed by T cell and antibody assays against a range of coronavirus variants.
REC name
North West - Liverpool Central Research Ethics Committee
REC reference
21/NW/0073
Date of REC Opinion
16 Mar 2021
REC opinion
Further Information Favourable Opinion